Lexaria Bioscience (LEXX) FCF Margin (QoQ) (2018 - 2025)
Lexaria Bioscience (LEXX) FCF Margin (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Lexaria Bioscience | 10.17 Mn | 6.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | 54,106.00 |
| May 31, 2025 | -119,889.00 |
| Feb 28, 2025 | 63,471.00 |
| Nov 30, 2024 | 80,762.00 |
| Aug 31, 2024 | -79,595.00 |
| May 31, 2024 | -107,991.00 |
| Feb 29, 2024 | 35,379.00 |
| Nov 30, 2023 | 449,419.00 |
| Aug 31, 2023 | -297,697.00 |
| May 31, 2023 | 390,154.00 |
| Feb 28, 2023 | -490,473.00 |
| Nov 30, 2022 | -23,656.00 |
| Aug 31, 2022 | 21,095.00 |
| May 31, 2022 | 289,774.00 |
| Feb 28, 2022 | 454,093.00 |
| Nov 30, 2021 | -512,293.00 |
| Aug 31, 2021 | -301,842.00 |
| May 31, 2021 | -23,464.00 |
| Feb 28, 2021 | -5,841.00 |
| Nov 30, 2020 | 72,534.00 |